By age 60, 30 percent of Americans suffer from fat pad atrophy of the foot. Forefoot fat pad atrophy results from long-term aggressive activity, genetically dictated foot type, multiple forefoot steroid injections, surgery, and foot trauma.
The authors present data from a 2-year, prospective, randomized crossover study performed to assess pain and disability indexes, fat pad thickness, forces, and pressures of stance and gait. Group 1 underwent fat grafting with 2 years of follow-up, and group 2 underwent conservative management for 1 year, then underwent fat grafting with 1 year of follow-up.
Eighteen subjects (14 women and four men) constituted group 1. Thirteen subjects (nine women and four men) constituted group 2. Group 1 reported the worst pain at baseline and group 2 experienced the worst pain at 6- and 12-month standard-of-care visits; pain for both groups improved immediately following fat grafting and lasted through study follow-up (p < 0.05). Group 1 demonstrated functional improvements at 12, 18, and 24 months postoperatively (p < 0.05), whereas group 2 demonstrated the highest function at 12 months postoperatively (p < 0.05). Pedal fat pad thickness of subjects in group 1 increased postoperatively and returned to baseline thickness at 2 months postoperatively; subjects in group 2 experienced return to baseline thickness at 6 months postoperatively (p < 0.01). Forces and pressures of stance and gait increased over the 2 years of follow-up for group 1 (p < 0.05).
Pedal fat grafting provides long-lasting improvements in pain and function, and prevents against worsening from conservative management.
From the Department of Plastic Surgery, University of Pittsburgh.
Received for publication November 22, 2017; accepted May 1, 2018.
This trial is registered under the name “Fat Grafting for Pedal Fad Pad Atrophy,” ClinicalTrials.gov identification number NCT01796808 (https://clinicaltrials.gov/ct2/show/NCT01796808).
Presented at Plastic Surgery The Meeting 2017, Annual Meeting of the American Society of Plastic Surgeons, in Orlando, Florida, October 6 through 10, 2017; the 60th Ohio Valley Society of Plastic Surgeons Meeting, in Pittsburgh, Pennsylvania, June 2 through 4, 2017; and the 63rd Annual Scientific Meeting of the Robert H. Ivy Society, in Philadelphia, Pennsylvania, April 22, 2017.
Disclosure:The authors have no financial interest to declare in relation to the content of this article.
Supplemental digital content is available for this article. Direct URL citations appear in the text; simply type the URL address into any Web browser to access this content. Clickable links to the material are provided in the HTML text of this article on the Journal’s website (www.PRSJournal.com).
This work was supported by THE PLASTIC SURGERY FOUNDATION.
Jeffrey A. Gusenoff, M.D., 3380 Boulevard of the Allies, Suite 138, Pittsburgh, Pa. 15213, email@example.com